This includes clotting factor I (dysfibrogenemia), V, V and VIII, and X. Less common are factor I (afibrogenemia), II, and XIII, which occur at a rate of 5 in 10 million, 1 in 2 million, and 1 in ...

The FDA has approved Tretten (coagulation factor XIII A-subunit [recombinant]; Novo Nordisk) for use in the routine prevention of bleeding in adults and children who have congenital Factor XIII A ...

Factor XIII deficiency is a rare but potentially life‐threatening bleeding disorder that disrupts the final stage of clot stabilisation. As a multifunctional transglutaminase, Factor XIII plays ...

Factor XIII deficiency is one of the rarest coagulation disorders, with only 500 cases reported globally since 1960, the authors said.

Coagulation factor XIII Coagulation factor XIII (Corifact, Tretten) is prescribed to help manage bleeding in people with a rare genetic (inherited) bleeding disorder.

Factor II activity in vitro varied from 10.8 to 61.5 units, factor VII from 16.1 to 63.9 units, and factor X from 13.8 to 65.5 units per milliliter. (One unit of a clotting factor is the amount in ...

"Aside from COVID-19, I've never seen anything else cause markedly elevated factor V, and I've been doing this for 25 years," study co-author Dr. Elizabeth Van Cott said in a hospital news release.

Patients and Methods Factor V Leiden (rs6025), prothrombin G20210A (rs1799963), PAI-1 4G/5G (rs1799889), MTHFR 677C>T (rs1801133), fibrinogen gamma 10034C>T (rs2066865), and factor XIII Val34Leu ...

Send comments and news tips to [email protected]. Cite this: Gene Transfer Restores Clotting Factor Level in Hemophilia B - Medscape - Dec 13, 2011.